trial

Effects of Galantamine on Cognition

NCTId NCT01100775
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2 · Completed
Enrollment 12 (actual)
Sponsored by University of Maryland, Baltimore County
Primary completion 2014-08-21
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2
Status
Completed
Enrollment
12 (actual)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Triple
Start
2010-05
Primary completion
2014-08-21
Eligibility
ALL · 18 Years · 64 Years

Interventions & indications

Drugs
Galantamine

Sponsors

University of Maryland, Baltimore CountyLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

1
L. Elliot Hong, M.D.Principal Investigator

Sites

1 total
Baltimore, United States

Linked catalysts

1
Effects of Galantamine on Cognition — primary completion2014-08-21

Facts & assertions

4 sourced
Enrollment
12
Phase
PHASE2
Primary Completion Date
2014-08-21
Status
COMPLETED
relationships
The graph out of here
drug
Galantamine
drug
lead_sponsor
University of Maryland, Baltimore County
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
L. Elliot Hong, M.D.
person